Hub Genes Involved in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma

被引:2
作者
Liu, Baiyi [1 ]
Wang, Xiaoxiao [1 ]
Wu, Nan [1 ]
Liu, Feng [1 ]
Rao, Huiying [1 ]
机构
[1] Peking Univ Peoples Hosp, Peking Univ Hepatol Inst, Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing Int Cooperat Base Sci & Technol NAFLD Diag, Beijing, Peoples R China
关键词
Nonalcoholic fatty liver disease (NAFLD); hepatocellular carcinoma (HCC); biomarkers; progression; prognosis; FIBROSIS STAGE; INFLAMMATION; VERSICAN; CELLS; NASH; STEATOHEPATITIS; PREVALENCE; PLATELETS; APOPTOSIS; PROTEIN;
D O I
10.2174/0109298673288887240212065116
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. With an increasing number of patients, NAFLD has been identified as a risk factor for Hepatocellular Carcinoma (HCC). The precise pathophysiology of NAFLD-related HCC has not been completely understood recently.Objective We analyzed the hub genes related to NAFLD and HCC to predict the risk of NAFLD progressing to HCC.Methods Two datasets of NAFLD were used to identify differentially expressed genes. Lasso-Cox regression analysis was performed to determine a gene model to predict the risk of the progression from NAFLD to HCC. Three validation datasets were analyzed to evaluate the performance of the gene model, including normal and NAFLD with fibrosis, NAFLD with fibrosis and NAFLD-related HCC, and normal and NASH-related HCC.Results Seven genes, including COL1A1, TIPM1, VCAN, FOS, CD79A, CXCL9, and VWF, were identified as the hub genes, and then a gene model was constructed. By calculating, the area under the receiver operating characteristic curves (AUCs) for risk prediction were 0.97, 0.886, and 0.751 in the three validation datasets, respectively. Gene set enrichment analysis indicated that the MAPK, TGF beta, p53, PPAR, insulin signaling pathways, and fatty acid metabolism were significantly upregulated in the high-risk group. GTPase activity and intrinsic apoptotic signaling pathway had significant upregulation in the low-risk group.Conclusion The seven hub genes may predict the risk of NAFLD developing into HCC by mediating the potential molecular mechanism, which could be used as biomarkers for predicting the progression, diagnosis, and treatment of NAFLD.
引用
收藏
页数:21
相关论文
共 75 条
[1]   CXCL9-11 polymorphisms are associated with liver fibrosis in patients with chronic hepatitis C: a cross-sectional study [J].
Angeles Jimenez-Sousa, Maria ;
Zaida Gomez-Moreno, Ana ;
Pineda-Tenor, Daniel ;
Maria Medrano, Luz ;
Jose Sanchez-Ruano, Juan ;
Fernandez-Rodriguez, Amanda ;
Artaza-Varasa, Tomas ;
Saura-Montalban, Jose ;
Vazquez-Moron, Sonia ;
Ryan, Pablo ;
Resino, Salvador .
CLINICAL AND TRANSLATIONAL MEDICINE, 2017, 6
[2]   From NASH to HCC: current concepts and future challenges [J].
Anstee, Quentin M. ;
Reeves, Helen L. ;
Kotsiliti, Elena ;
Govaere, Olivier ;
Heikenwalder, Mathias .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2019, 16 (07) :411-428
[3]   MiR-4521 plays a tumor repressive role in growth and metastasis of hepatocarcinoma cells by suppressing phosphorylation of FAK/AKT pathway via targeting FAM129A [J].
Ayesha, Munawar ;
Majid, Abbasi ;
Zhao, Dongting ;
Greenaway, Frederick T. ;
Yan, Naimeng ;
Liu, Qinlong ;
Liu, Shuqing ;
Sun, Ming-Zhong .
JOURNAL OF ADVANCED RESEARCH, 2022, 36 :147-161
[4]   Liver carcinogenesis by FOS-dependent inflammation and cholesterol dysregulation [J].
Bakiri, Latifa ;
Hamacher, Rainer ;
Grana, Osvaldo ;
Guio-Carrion, Ana ;
Campos-Olivas, Ramon ;
Martinez, Lola ;
Dienes, Hans P. ;
Thomsen, Martin K. ;
Hasenfuss, Sebastian C. ;
Wagner, Erwin F. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2017, 214 (05) :1387-1409
[5]   Emergence of highly profibrotic and proinflammatory Lrat+ FbIn2+ HSC subpopulation in alcoholic hepatitis [J].
Balog, Steven ;
Fujiwara, Reika ;
Pan, Stephanie Q. ;
El-Baradie, Khairat B. ;
Choi, Hye Yeon ;
Sinha, Sonal ;
Yang, Qihong ;
Asahina, Kinji ;
Chen, Yibu ;
Li, Meng ;
Salomon, Matthew ;
Ng, Stanley W-K ;
Tsukamoto, Hidekazu .
HEPATOLOGY, 2023, 78 (01) :212-224
[6]   Versican: a novel modulator of hepatic fibrosis [J].
Bukong, Terence N. ;
Maurice, Sean B. ;
Chahal, Barinder ;
Schaeffer, David F. ;
Winwood, Paul J. .
LABORATORY INVESTIGATION, 2016, 96 (03) :361-374
[7]   MicroRNA-29c Acting on FOS Plays a Significant Role in Nonalcoholic Steatohepatitis Through the Interleukin-17 Signaling Pathway [J].
Cai, Chao ;
Chen, Da-Zhi ;
Tu, Han-Xiao ;
Chen, Wen-Kai ;
Ge, Li-Chao ;
Fu, Tian-Tian ;
Tao, Ying ;
Ye, Sha-Sha ;
Li, Ji ;
Lin, Zhuo ;
Wang, Xiao-Dong ;
Xu, Lan-Man ;
Chen, Yong-Ping .
FRONTIERS IN PHYSIOLOGY, 2021, 12
[8]   Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease [J].
Castera, Laurent ;
Friedrich-Rust, Mireen ;
Loomba, Rohit .
GASTROENTEROLOGY, 2019, 156 (05) :1264-+
[9]   clusterProfiler 4.0: A universal enrichment tool for interpreting omics data [J].
Wu, Tianzhi ;
Hu, Erqiang ;
Xu, Shuangbin ;
Chen, Meijun ;
Guo, Pingfan ;
Dai, Zehan ;
Feng, Tingze ;
Zhou, Lang ;
Tang, Wenli ;
Zhan, Li ;
Fu, Xiaocong ;
Liu, Shanshan ;
Bo, Xiaochen ;
Yu, Guangchuang .
INNOVATION, 2021, 2 (03)
[10]   Platelets: No longer bystanders in liver disease [J].
Chauhan, Abhishek ;
Adams, David H. ;
Watson, Steve P. ;
Lalor, Patricia F. .
HEPATOLOGY, 2016, 64 (05) :1774-1784